Research article summary (published 30 May 2008):

[Characteristics of hematological malignancies in the elderly]

Full Abstract

No abstract is currently available for this article. See 'Journal and Publication Information' further down the page for details that may assist you in locating this article in electronic or hard copy media. The 'Related articles' section also further down the page, where available, may show links to abstracts of articles covering similar topics.

Author information

Author/s: Ohta, Masatsugu (M);

Journal and publication information

Publication Type: Journal Article; Review

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology (Rinsho Ketsueki), published in Japan. (Language: jpn)

Reference: 2008-Jun; vol 49 (issue 6) : pp 382-9

Dates: Created 2008/07/23; Completed 2008/09/11;

PMID: 18646605, status: MEDLINE (last retrieved date: 2/18/2009)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MeSH Headings (categories) shown below.

Aged Aged, 80 and over Aging Aminoglycosides - administration & dosage Antibodies, Monoclonal - administration & dosage Antineoplastic Combined Chemotherapy Protocols - administration & dosage Cognition Disorders Community Health Services Evidence-Based Medicine

Evidence-Based Medicine Gene Therapy Hematologic Neoplasms - classification; psychology; therapy Hematopoietic Stem Cell Transplantation Humans Informed Consent Patient Care Team Quality of Life Transplantation Conditioning

Note: Bold headings indicate primary MeSH headings or qualifiers.

Associated Chemicals: Aminoglycosides (0) ; Antibodies, Monoclonal (0) ; gemtuzumab (0)

Related articles

These are the most related articles currently in our database:

• [Hematological malignancies] 27 Feb 2007
• Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning. 30 Dec 2004
• Quality of life in Thai patients after bone marrow and peripheral blood stem cell transplantation: a comparison study with patients treated with conventional chemotherapy. 29 Sep 1999
• Monoclonal antibodies for the treatment of hematologic malignancies: schedule and maintenance therapy. 30 Mar 2008
• Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant. 30 Aug 2001
• High-dose chemotherapy with autologous stem cell transplantation is feasible and safe in a regional hospital. A 6-year experience in southern Switzerland. 30 Dec 1996
• Assessment of quality of life during intensive chemotherapy or bone marrow transplantation. 30 Dec 1998
• [Suppressive effect of high-dose chemotherapy (HDC) on the clonal growth of grafted peripheral blood granulocyte progenitors is reduced 72 hours after completion of HDC] 29 Apr 2005
• Very low toxicity and good quality of life in 48 elderly patients autotransplanted for hematological malignancies: a single center experience. 30 May 2001
• Treatment of hematologic malignancies with alternate hemibody irradiation combined with high-dose chemotherapy: a single-center experience. 29 Nov 2004

See 100+ related articles.

Related Article Map

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a larger map of 100+ related articles.